Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04HMK
|
|||
| Former ID |
DIB005211
|
|||
| Drug Name |
Hi8 melanoma vaccine
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 2 | [1] | |
| Company |
Oxford BioMedica
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Phase I/II trial of Hi8 PrimeBoost therapeutic vaccine in stage III/IV metastatic melanoma. Melanoma Research. 09/2006; 16(Supplement 1). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.